News StoriesExcerpts of Key News Stories in Major Media
Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
The number of kids in America living with autism is apparently growing at a considerable rate, according to a new study. Published in JAMA Pediatrics ... the new study reveals a nearly 52% increase in autism spectrum disorder diagnoses among children in the United States between 2017 and 2020. The National Institute of Mental Health says that "autism spectrum disorder (ASD) is a neurological and developmental disorder that affects how people interact with others, communicate, learn, and behave." One out of every 30 kids in America has that developmental disorder. ASD rates in American kids have been rising since 2014, only dipping slightly in 2016 and 2017 before resuming the increasing pattern all the way to 2020. The Centers for Disease Control and Prevention (CDC) conducts the National Health Interview Survey every year. The survey data shows that about 2.24% of kids were diagnosed with ASD in 2014, which climbed all the way to 2.76% before dipping to 2.29% in 2017. As of 2020, the percentage of American youth who have been diagnosed with ASD has reached 3.49%. Around 4.64% of boys were diagnosed with ASD, while only 1.56% of girls received the same diagnosis.
Note: Such a huge problem, yet almost no studies comparing non-vaccinated children with those vaccinated. One of the few studies conducted show unvaccinated children were healthier. An investigation of Amish children found practically no cases of autism. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
Sen. Rand Paul (R-KY) has been heavily criticized by those on the Left for fighting back against mask and vaccine mandates. He was censored by Big Tech and vilified by Democratic politicians. Consider the recent admission by Dr. Deborah Birx regarding the efficacy of the COVID-19 vaccines. Birx, the former White House COVID response coordinator, stated in an interview with Neil Cavuto on Fox News that she knew the vaccines wouldn't stop infections. Birx's comments align with what Paul was saying last year regarding the vaccines and the sycophantic nature in which Democrats were pushing them on the public. "I knew these vaccines were not going to protect against infection," Birx said. "I think we overplayed the vaccines, and it made people then worry that it's not going to protect against severe disease and hospitalization. It will. But let's be very clear: 50% of the people who died from the omicron surge were older, vaccinated." Consider Paul's comments in an exchange with Department of Health and Human Services Secretary Xavier Becerra last September. Paul challenged Becerra on the efficacy of vaccines compared to natural immunity. At the time, Paul was one of only a few people who challenged those in charge. Some even claimed Paul's words were causing people to die. As it turns out, Paul was right, and they were wrong. "The science is against you on this. The science is clear. Naturally acquired immunity is as good as a vaccine," Paul said.
Note: Watch the revealing interview where Dr. Birx makes these comments. Note that Birx is promoting Paxlovid for which the gov't pays $530 per person and is offering free of charge. So who do you think pays for this ultimately? And who profits? The official narrative on COVID is falling apart as shown in the evidence in this great article. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Pfizer made nearly $37bn (Ł27bn) in sales from its Covid-19 vaccine last year – making it one of the most lucrative products in history – and has forecast another bumper year in 2022, with a big boost coming from its Covid-19 pill Paxlovid. The US drugmaker's overall revenues in 2021 doubled to $81.3bn. The bumper sales prompted accusations from campaigners of "pandemic profiteering". The group Global Justice Now said the annual revenue of $81bn was more than the GDP of most countries. Pharmaceutical companies have been accused of not sharing the recipe for their vaccines, which would enable drugmakers in poorer countries to produce cheaper versions of them. Global Justice Now pointed out that Pfizer's Covid-19 jab was invented by BioNTech, supported by â‚Ź100m (Ł84m) in debt financing from the publicly owned European Investment Bank and a â‚Ź375m grant from the German government. Tim Bierley, a pharma campaigner at the group, said: "The development of mRNA vaccines should have revolutionised the global Covid response. "But we've let Pfizer withhold this essential medical innovation from much of the world, all while ripping off public health systems." According to Reuters, Pfizer has sold the vaccine to African countries at $3 to $10 a shot. It has indicated that a non-profit dose costs just $6.75, or Ł4.98, to produce, but it has reportedly charged the NHS Ł18 a dose for the first 100m jabs bought and Ł22 a dose for the next 89m, totalling Ł3.76bn ... amounting to an eye-watering 299% mark-up.
Note: If big Pharma really cared about public healthy, don't you think they'd be willing to sacrifice some of their huge profits and charge much less for their injections? Unfortunately, it's the old story of the rich get richer and the rest are left behind. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.
Medicare's drug program could have saved up to $3.6 billion in 2020 by mirroring the pricing strategy of entrepreneur and Shark Tank judge Mark Cuban's online pharmacy, according to a new study. Cuban's Cost Plus Drug Co. offers a selection of generic drugs at the cost of manufacturing them plus a flat 15% markup. The direct-to-consumer pharmacy does not accept insurance. The study's authors suggest that Medicare is overpaying for many generic drugs and could save billions a year if it purchased them directly from Cuban's online pharmacy. "The lower prices from a direct-to-consumer model highlight inefficiencies in the existing generic pharmaceutical distribution and reimbursement system, which includes wholesalers, pharmacy benefit managers, pharmacies, and insurers," wrote researchers at Brigham and Women's Hospital and Harvard Medical School in a brief published ... in the journal Annals of Internal Medicine. Cuban and his pharmacy did not fund or have any involvement in the study. Cost Plus Drug Co. says it engages in price negotiations with drugmakers. Medicare's drug program, Part D, however, prohibits the government from directly negotiating pharmaceutical prices. Researchers compared 2020 Medicare spending for a total of 89 drugs ... to their prices at Cost Plus Drug Co. in February. They estimate that Medicare overpaid for 77 generic drugs, spending $8.1 billion compared with $4.5 billion if the federal agency had purchased at the same prices as Cost Plus Drug Co. charges.
Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and Big Pharma profiteering from reliable major media sources.
On September 19, 2019, House Speaker Nancy Pelosi introduced the Elijah Cummings Lower Drug Costs Now Act. The bill ... would allow the federal government to negotiate drug prices on behalf of Medicare, a right assumed by the governments of every other major economy. Polls showed support ranging from 80 to an eye-popping 90-plus percent. H.R. 3 was delivered stillborn into Mitch McConnell's Senate in November of 2019. Two years later, when Joe Biden released the massive social-spending and climate-change bill dubbed Build Back Better, H.R. 3's reforms were nowhere to be found. And at every level of government, Pharma's endless river of money continues to flow, the widest, steadiest current of lobbying largesse the capitol has ever known. In 2021, the industry reported spending $124 million on a fleet of 846 lobbyists, roughly two for every member of Congress. Sixty-five percent were former government employees. Pharmaceutical manufacturers are part of a larger coalition that includes the insurance, medical-device, and hospital industries. Its combined resources flow downstream through dozens of lobbying firms, communications shops, and front groups. "If a freshman Democrat so much as signs a letter related to drug prices, the lobby hammers them with phone calls and meeting requests, completely locking up the calendar," says Alex Lawson, executive director of Social Security Works. "The calls come in from ex-Democratic officials and staffers, so they have to take the meetings."
Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and Big Pharma profiteering from reliable major media sources.
Why have so many smart, well-trained doctors stood by as American healthcare descended into a state of profound dysfunction? The answer lies in the gradual, nearly invisible commercial takeover of the medical "knowledge" that doctors are trained to trust. In 1981, President Ronald Reagan slashed government support of university-based medical research. Following the 1980 passage of the University and Small Business Patent Procedures Act, nonprofit institutions and their researchers were allowed to benefit financially from the discoveries made while conducting federally funded research. Over the past few decades, the drug companies have taken over most of our clinical research. In 1991, academic medical centers (AMCs)–hospitals that train doctors and conduct medical research–received 80 percent of the money that industry was spending to fund clinical trials. But by 2004, the percentage of commercially funded clinical trials conducted by AMCs had fallen from 80 to just 26 percent. That ... allowed the commercial funder to own, and thus control, the data from jointly conducted research. Unbeknownst to almost all doctors, peer reviewers are not granted access to the underlying data that serves as the basis for the reported findings. The drug companies own that data and keep it confidential. Reviewers must rely on brief data summaries. Peer reviewers at even the most prestigious medical journals cannot possibly attest to the accuracy and completeness of the articles they review.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in science and Big Pharma profiteering from reliable major media sources.
Small teams of U.S. Special Operations forces are involved in a low-profile proxy war program on a far greater scale than previously known. While The Intercept and other outlets have previously reported on the Pentagon's use of the secretive 127e authority in multiple African countries, a new document obtained through the Freedom of Information Act offers the first official confirmation that at least 14 127e programs were also active in the greater Middle East and the Asia-Pacific region as recently as 2020. In total, between 2017 and 2020, U.S. commandos conducted at least 23 separate 127e programs across the world. Separately, Joseph Votel, a retired four-star Army general who headed both Special Operations Command and Central Command, which oversees U.S. military efforts in the Middle East, confirmed the existence of previously unrevealed 127e "counterterrorism" efforts in Egypt, Lebanon, Syria, and Yemen. Basic information about these missions – where they are conducted, their frequency and targets, and the foreign forces the U.S. relies on to carry them out – are unknown even to most members of relevant congressional committees and key State Department personnel. Through 127e, the U.S. arms, trains, and provides intelligence to foreign forces. 127e partners are then dispatched on U.S.-directed missions, targeting U.S. enemies to achieve U.S. aims. "If someone were to call a 127-echo program a proxy operation, it would be hard to argue with them," [said a former senior defense official].
Note: For more along these lines, see concise summaries of deeply revealing news articles on military corruption from reliable major media sources.
When the Federal Reserve needed Wall Street's help with its pandemic rescue mission, it went straight to Larry Fink. The BlackRock cofounder, chairman, and chief executive officer has become one of the industry's most important government whisperers. The company's new assignment is a much bigger version of one it took on after the 2008 financial crisis, when the Federal Reserve enlisted it to dispose of toxic mortgage securities. This time it will help the Fed prop up the entire corporate bond market by purchasing, on the central bank's behalf, what could become a $750 billion portfolio of debt. One part of the Fed's plan is to buy bond exchange-traded funds. BlackRock itself runs ETFs under the iShares brand, and could end up buying funds it manages. "BlackRock is acting as a fiduciary to the Federal Reserve Bank of New York," says a spokesman for the company. "As such, BlackRock will execute this mandate at the sole discretion of the bank." The arrangement is bringing new attention to the company's scale and ubiquity. "It's impossible to think of BlackRock without thinking of them as a fourth branch of government," says William Birdthistle, a professor at the Chicago-Kent College of Law. BlackRock's growth raises questions over how big and useful a company can become before its size poses a risk. And then there are the potential conflicts. One arm of BlackRock knows what the Fed is buying, while other parts of the business participating in credit markets could benefit from that knowledge.
Note: Watch an excellent documentary showing how BlackRock, Vanguard, and several other institutions are the largest shareholders in almost every major corporation you can think of. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the financial industry from reliable major media sources.
Doramise Moreau toils long past midnight in her tiny kitchen every Friday – boiling lemon peels, crushing fragrant garlic and onion into a spice blend she rubs onto chicken and turkey, cooking the dried beans that accompany the yellow rice she'll deliver to a Miami church. She's singlehandedly cooked 1,000 meals a week since the pandemic's start – an act of love she's content to perform with little compensation. Moreau, a 60-year-old widow who lives with her children, nephew and three grandchildren, cooks in the kitchen of a home built by Habitat for Humanity in 2017. Her days are arduous. She works part-time as a janitor at a technical school, walking or taking the bus. But the work of her heart, the reason she rises each morning, is feeding the hungry. As a little girl in Haiti, she often pilfered food from her parents' pantry – some dried rice and beans, maybe an onion or an ear of corn – to give to someone who needed it. Her mother was furious, constantly scolding and threatening Moreau, even telling the priest to refuse to give her communion. But she was not deterred. Decades later, Moreau is still feeding the hungry. She borrows the church truck to buy groceries on Thursday and Friday and cooks into the wee hours of the night for Saturday's feedings. Notre Dame d'Haiti Catholic Church pays for the food, relying on donations. Moreau prepares the meals singlehandedly, while church volunteers serve or deliver them to shut-ins.
Note: Enjoy a wonderful compilation of inspiring stories from the pandemic times on this webpage. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
Spain has announced it will make some short- and middle-distance train journeys completely free as the government seeks to combat the impact of the cost-of-living crisis. Spanish prime minister Pedro Sánchez said on Tuesday that all CercanĂas (commuter trains), Rodalies (commuter routes in Catalonia) and Media Distancia routes (mid-distance regional lines which cover distances less than 300km) run by the national rail system will be free from 1 September 1 to 31 December this year. The 100% discount will only apply to multi-trip tickets. The new scheme comes in addition to the government funding a discount of between 30-50% on all public transport - including metros, buses and trams. Spanish inflation has accelerated in the past few months and surpassed 10% for the first time in 37 years during the 12 months to June. Sanchez said soaring inflation was the biggest challenge for Spain, likening it to "a serious illness of our economy that impoverishes everyone, especially the most vulnerable groups". He also announced 100 euros a month in complementary scholarships for students older than 16 years who already receive scholarships. "I am fully aware of the daily difficulties that most people face. I know that your salary is getting less and less, that it is difficult to make ends meet, and that your shopping basket is becoming more and more expensive", Sánchez said. On Thursday, the European Commission warned inflation could hit historic highs of 7.6%, up from last month's prediction of 6.1%.
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
Why is physical activity so good for us as we age? According to a novel new theory about exercise, evolution and aging, the answer lies, in part, in our ancestral need for grandparents. The theory, called the "Active Grandparent Hypothesis" and detailed in a recent editorial in Proceedings of the National Academy of Sciences, suggests that in the early days of our species, hunter-gatherers who lived past their childbearing years could pitch in and provide extra sustenance and succor to their grandchildren, helping those descendants survive. The theory also makes the case that it was physical activity that helped hunter-gatherers survive long enough to become grandparents – an idea that has potential relevance for us today, because it may explain why exercise is good for us in the first place. Early humans had to move around often to hunt for food, the thinking goes, and those who moved the most and found the most food were likeliest to survive. Over eons, this process led to the selection of genes that were optimized by plentiful physical activity. Evolution favored the most active tribespeople, who tended to live the longest and could then step in to help with the grandchildren, furthering active families' survival. In other words, exercise is good for us ... because long ago, the youngest and most vulnerable humans needed grandparents, and those grandparents needed to be vigorous and mobile to help keep the grandkids nourished.
Note: Learn more about the importance of grandparents in this Smithsonian article. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
Over the past decades, regulatory agencies have seen large proportions of their budgets funded by the industry they are sworn to regulate. In 1992, the US Congress passed the Prescription Drug User Fee Act (PDUFA), allowing industry to fund the US Food and Drug Administration (FDA) directly through "user fees." The FDA moved from a fully taxpayer funded entity to one supplemented by industry money. Net PDUFA fees collected have increased 30 fold–from around $29m in 1993 to $884m in 2016. In Europe, industry fees funded 20% of ... the European Medicines Agency (EMA), in 1995. By 2010 that had risen to 75%; today it is 89%. Australia had the highest proportion of budget from industry fees (96%) and in 2020-2021 approved more than nine of every 10 drug company applications. But for decades academics have raised questions about the influence funding has on regulatory decisions, especially in the wake of a string of drug and device scandals–including opioids, Alzheimer's drugs, influenza antivirals, pelvic mesh, joint prostheses, breast and contraceptive implants, cardiac stents, and pacemakers. An analysis of three decades of PDUFA in the US has shown how a reliance on industry fees is contributing to a decline in evidentiary standards, ultimately harming patients. A BMJ investigation last year found several expert advisers for covid-19 vaccine advisory committees in the UK and US had financial ties with vaccine manufacturers–ties the regulators judged as acceptable.
Note: For more on this massive legal corruption, see this article. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in Big Pharma from reliable major media sources.
Lockdowns had "little to no effect" on saving lives during the pandemic – and "should be rejected out of hand as a pandemic policy," according to a controversial meta-analysis of dozens of studies. A group led by the head of Johns Hopkins Institute for Applied Economics analyzed studies from the first surge of the pandemic to investigate widely pushed claims that stringent restrictions would limit deaths. Instead, the meta-analysis concluded that lockdowns across the US and Europe had only "reduced COVID-19 mortality by 0.2% on average." Worse, some of the studies even suggested that limiting gatherings in safe outdoor spots may have been "counterproductive and increased" the death rate, the authors noted in the non-peer-reviewed preprint. "While this meta-analysis concludes that lockdowns have had little to no public health effects, they have imposed enormous economic and social costs where they have been adopted," the professors wrote in the journal Studies in Applied Economics. In fact, the early lockdowns "have had devastating effects," the authors insisted. "They have contributed to reducing economic activity, raising unemployment, reducing schooling, causing political unrest, contributing to domestic violence, and undermining liberal democracy," the damning report insisted. "Such a standard benefit-cost calculation leads to a strong conclusion: lockdowns should be rejected out of hand as a pandemic policy instrument," the authors said of the "ill-founded" measures.
Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.
"It's like a horror movie I'm being forced to watch and I can't close my eyes," one senior FDA official lamented. That particular FDA doctor was referring to two recent developments inside the agency. First, how, with no solid clinical data, the agency authorized COVID vaccines for infants and toddlers, including those who already had COVID. And second, [how] the FDA bypassed its external experts to authorize booster shots for young children. That doctor is hardly alone. At the NIH, doctors and scientists complain to us about low morale and lower staffing: The NIH's Vaccine Research Center has had many of its senior scientists leave over the last year, including the director, deputy director and chief medical officer. The CDC has experienced a similar exodus. "There's been a large amount of turnover. Morale is low," one high level official at the CDC told us. "Things have become so political, so what are we there for?" Another CDC scientist told us: "I used to be proud to tell people I work at the CDC. Now I'm embarrassed." Why are they embarrassed? First, they demanded that young children be masked in schools. On this score, the agencies were wrong. Compelling studies later found schools that masked children had no different rates of transmission. Next came school closures. The agencies were wrong – and catastrophically so. Poor and minority children suffered learning loss with an 11-point drop in math scores alone and a 20% drop in math pass rates. Then they ignored natural immunity. Wrong again.
Note: Why are so few media reporting on this most important news? For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.
Pension funds, investment firms and Wall Street banks are snapping up family homes in Europe and the United States at a rapid pace as prices rocket higher. At the same time, the soaring cost of home ownership means that growing numbers of younger Americans and Brits renting rather than buying houses as they start families. Some of them may find their next landlord is based on Wall Street or in London's financial district. Analysts argue that this will improve standards in the rental sector. But some tenants who rent from corporate landlords dispute this, alleging substandard services and excessive rent increases. If investors are hoovering up existing properties that would otherwise have been sold to individuals, that could squeeze out first-time buyers. Household incomes in the United States and United Kingdom have not kept pace with rising home values in recent years, a trend made worse by the pandemic, which has sent average house prices in both markets to record highs. Invitation Homes, America's biggest single-family home leasing company with some 81,000 houses, is currently facing two lawsuits brought by tenants in California and Maryland who claim that the company's late rent fees constitute illegal penalties under state laws. Current and former tenants of the company ... painted a picture of an uncaring landlord, slow to make repairs and quick to threaten eviction when rent payments are overdue or withheld because of unresolved maintenance issues.
Note: For more along these lines, see concise summaries of deeply revealing news articles on financial industry corruption and income inequality from reliable major media sources.
The US Supreme Court let stand an $87 million award against Bayer AG, rejecting the company for the second time in a week as it tries to fend off tens of thousands of claims that its top-selling Roundup weedkiller causes cancer. The justices, making no comment, on Monday left in place a jury's finding in favor of Alva and Alberta Pilliod in a California case. Bayer argued that a federal law precluded the suit and that the $70 million punitive damages award was so large it violated the Constitution. The court last week rejected Bayer's appeal in a case the company was trying to use to scuttle billions of dollars in potential claims. The company's liability could be the full $16 billion it has set aside to resolve the litigation, according to Bloomberg Intelligence analyst Holly Froum. Earlier this month, a federal appeals court ordered the US Environmental Protection Agency to take another look at whether glyphosate - Roundup's active ingredient - is a carcinogen. Studies have linked it to some cancers. The German chemicals giant said it "is fully prepared to manage the litigation risk associated with potential future claims in the US as previously communicated in July 2021, including a voluntary claims program, transition of active ingredients for glyphosate-based products in the US." Bayer inherited the legal mess in 2018 when it acquired Monsanto Co., the herbicide's maker. Bayer has won four of seven Roundup trials so far, with all its losses occurring in California courts. The case is Monsanto v. Pilliod, 21-1272.
Note: Instead of relying on independent science, the EPA used industry studies to determine that glyphosate was safe. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.
California will begin making its own low-cost insulin in an effort to make the essential diabetes treatment more affordable, Gov. Gavin Newsom announced on Thursday. "Nothing epitomizes market failures more than the cost of insulin," the governor said in a video posted on Twitter, "Many Americans experience out-of-pocket costs anywhere from three hundred to five hundred dollars per month for this life-saving drug." With a budget of $100 million, California plans to "contract and make our own insulin at a cheaper price, close to at cost, and to make it available to all," Newsom said. It's unclear exactly how inexpensive California's insulin will be or when the low-cost drugs will be available. Insulin in the U.S. costs almost $100 per unit, on average. That's nearly four times the price in Chile, which has the second-highest prices among the 34 countries analyzed by the nonprofit Rand Corporation, at less than $25 per unit. Currently, four in five Americans in need of insulin have incurred thousands of dollars in credit card debt to pay for the medication, according to a recent survey commissioned by health care organization CharityRx. The average debt among all survey participants was $9,000. California's program will allot $50 million toward the development of cheaper insulin products and $50 million on an in-state insulin manufacturing facility, Newsom said, adding that the facility "will provide new, high-paying jobs and a stronger supply chain for the drugs."
Note: The unethical corruption of big Pharma is so clearly seen in the ridiculously inflated prices of drugs in the US compared to other countries. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.
There's a hidden ingredient used as a whitener in an array of foods, from candies and pastries to cheeses and gum. It's called titanium dioxide, and while commonly used in the US, it's being banned in the EU as a possible carcinogen. The additive, also known as E171, joins a host of other chemicals that are banned in foods in the European Union but allowed in the US. These include Azodicarbonamide, a whitening agent found in food such as breads, bagels, pizza, and pastries in the US, which has been banned in the EU for more than a decade. Known as the "yoga mat'' chemical because it is often found in foamed plastic, the additive has been linked to asthma and respiratory issues in exposed workers and, when baked, to cancer in mice studies. Potassium bromate, an oxidizing agent often found in bread and dough and linked in animal studies to kidney and thyroid cancers, has been banned in the EU since 1990 but is still commonly used in the US. Brominated vegetable oil is also banned in the EU but is used as an emulsifier in citrus sodas and drinks in the US. Long-term exposure has been linked to headaches, memory loss and impaired coordination. The Food and Drug Administration classifies these food chemicals, and many others prohibited by the EU, as "generally recognized as safe". Chemical safety processes in the EU and US work in starkly different ways. Where European policy tends to take a precautionary approach – trying to prevent harm before it happens – the US is usually more reactive.
Note: For more along these lines, see concise summaries of deeply revealing news articles on food system corruption from reliable major media sources.
Nightmare stories of nurses giving potent drugs meant for one patient to another and surgeons removing the wrong body parts have dominated recent headlines about medical care. Lest you assume those cases are the exceptions, a new study by patient-safety researchers provides some context. Their analysis, published in the BMJ ... shows that "medical errors" in hospitals and other health-care facilities are incredibly common and may now be the third-leading cause of death in the United States – claiming 251,000 lives every year, more than respiratory disease, accidents, stroke and Alzheimer's. Martin Makary, a professor of surgery at the Johns Hopkins University School of Medicine ... led the research. Makary's research involves a ... comprehensive analysis of four large studies, including ones by the Health and Human Services Department's Office of the Inspector General and the Agency for Healthcare Research and Quality that took place between 2000 to 2008. His calculation of 251,000 deaths equates to nearly 700 deaths a day – about 9.5 percent of all deaths annually in the United States. Although all providers extol patient safety and highlight the various safety committees and protocols they have in place, few provide the public with specifics on actual cases of harm due to mistakes. Moreover, the Centers for Disease Control and Prevention doesn't require reporting of errors in the data it collects about deaths through billing codes, making it hard to see what's going on at the national level.
Note: Read lots more about this disturbing fact. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.
India on Friday imposed a ban on single-use plastics on items ranging from straws to cigarette packets to combat worsening pollution in a country whose streets are strewn with waste. Announcing the ban, the government dismissed the demands of food, beverage and consumer goods companies to hold off the restriction to avoid disruptions. Plastic waste has become a significant source of pollution in India, the world's second most populous country. Rapid economic growth has fueled demand for goods that come with single-use plastic products, such as straws and disposable cutlery. But India, which uses about 14 million tons of plastic annually, lacks an organized system for managing plastic waste, leading to widespread littering. India's ban on single-use plastic items includes straws, cutlery, ear buds, packaging films, plastic sticks for balloons, candy and ice-cream, and cigarette packets, among other products, Prime Minister Narendra Modi's government said. PepsiCo, Coca-Cola, India's Parle Agro, Dabur and Amul had lobbied for straws to be exempted from the ban. In a relief to consumers, the government has for now exempted plastic bags but it has asked manufacturers and importers to raise the thickness to promote reuse. Some experts believe that enforcing the ban might be difficult. The government has decided to set up control rooms to check any illegal use, sale and distribution of single-use plastic products.
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.